{
    "Trade/Device Name(s)": [
        "PixoTest POCT System",
        "PixoTest POCT Analyzer",
        "PixoTest A1c Test Kit"
    ],
    "Submitter Information": "iXensor Co. Ltd.",
    "510(k) Number": "K192369",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCP"
    ],
    "Summary Letter Date": "August 28, 2019",
    "Summary Letter Received Date": "August 30, 2019",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 864.7470"
    ],
    "Regulation Name(s)": [
        "Glycosylated Hemoglobin Assay"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glycated hemoglobin (HbA1c)"
    ],
    "Specimen Type(s)": [
        "Fingerstick capillary whole blood",
        "Venous whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "PixoTest POCT Analyzer"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "System",
        "Analyzer",
        "Test Kit"
    ],
    "Document Summary": "FDA 510(k) summary for PixoTest POCT System comprising PixoTest POCT Analyzer and PixoTest A1c Test Kit for quantitative measurement of HbA1c in whole blood.",
    "Indications for Use Summary": "Used for quantitative measurement of glycated hemoglobin (%HbA1c) in fingerstick capillary and venous whole blood to monitor long term glycemic control in individuals with diagnosed diabetes mellitus; intended for clinical laboratory and point-of-care professional use, not for diagnosis or screening of diabetes or use on neonates.",
    "fda_folder": "Hematology"
}